Fig. 13From: Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinomaThe clinical significance of RFESD in HCC and in vitro study. A Transfection efficiency was verified after transfection of RFESD or negative control siRNA. B HCC cell viability was evaluated with CCK-8 assays at 0, 24, 48, and 72 h post-transfection. C The growth of HCC cells was estimated by EdU assays after RFESD knockdownBack to article page